The effect of a single shot of Gentamicin on patient outcomes V 1.1
Research type
Research Study
Full title
The effect of a 40mg/ml single shot of Gentamicin on Vestibular function, hearing loss and patient satisfaction.
IRAS ID
158406
Contact name
Scott Richards
Contact email
Sponsor organisation
Aston University
Duration of Study in the UK
0 years, 5 months, 24 days
Research summary
This study has been designed to look at the vestibular function, remaining hearing and patient satisfaction post intra-tympanic gentamicin treatment. Gentamicin is known to have an effect on vestibular function and is now commonly used as a form of chemical labyrinthectomy to treat Menieres. There are no direct guidelines as to the correct dosage and treatment regime for Gentamicin, this study will be looking at the effectiveness of a single shot of 40mg/ml Gentamicin taking into consideration the vestibular function, remaining hearing and patient satisfaction. It will be a cross sectional study looking at patients post treatment, the data for the vestibular function and hearing will be collected retrospectively and the participants will not need to attend any additional appointments to collect this data. The participants will be contacted and invited to take part in the study, they will be required to complete a written consent form and complete a short postal questionnaire. The data will be anonymised and then analysed appropriately.
REC name
London - Brent Research Ethics Committee
REC reference
14/LO/1853
Date of REC Opinion
21 Oct 2014
REC opinion
Favourable Opinion